Published in:
03-08-2023 | AL Amyloidosis | Brief Report
Coinciding kappa AL amyloidosis and kappa light chain deposition disease in the lung
Authors:
Derald D. Charles, Elizabeth N. Pavlisko, Jadee L. Neff, Yubin Kang, John M. Carney
Published in:
Virchows Archiv
|
Issue 5/2023
Login to get access
Excerpt
Amyloid is primarily composed of insoluble extracellular fibrillar protein aggregates arranged in anti-parallel beta pleated sheet secondary structures that appear as amorphous, eosinophilic extracellular deposits when stained with hematoxylin and eosin (H&E) [
1,
2]. After Congo red staining, these microscopically appear yellow-green under polarized light [
1,
2]. The resulting structure is resistant to protease and able to self-propagate [
1,
2]. Accumulation of amyloid in tissues may be localized to an organ, or, in more serious cases, systemic—resulting in physiologic derangements [
1,
3]. Monoclonal immunoglobulin light chains produced by B cells or plasma cells are an amyloid precursor protein for amyloid light chain (AL) amyloidosis [
2,
3]. Localized AL amyloidosis is most often composed of kappa light chains—compared to lambda AL amyloidosis predominating in systemic forms [
3]. In the lung, localized amyloidosis often presents as slow-growing circumscribed nodules, classified as nodular amyloidosis, which may take on cystic features [
3]. …